Skip to main content
Top
Published in: Drugs & Aging 10/2013

01-10-2013 | Systematic Review

Aging, Antiretrovirals, and Adherence: A Meta Analysis of Adherence among Older HIV-Infected Individuals

Authors: Luwam Ghidei, Mark J. Simone, Marci J. Salow, Kristin M. Zimmerman, Allison M. Paquin, Lara M. Skarf, Tia R. M. Kostas, James L. Rudolph

Published in: Drugs & Aging | Issue 10/2013

Login to get access

Abstract

Introduction

Older adults are generally considered to be at greater risk for medication non-adherence due to factors such as medication complexity, side effects, cost, and cognitive decline. However, this generalization may not apply to older adults with human immunodeficiency virus (HIV). Regardless of age, suboptimal adherence to antiretroviral therapy (ART) can lead to increased viral load, immunosuppression, drug-resistant viral strains, co-morbidities, and opportunistic infections. Understanding trends of adherence to ART among older adults is critical, especially as the population of people living with HIV grows older.

Objectives

The purpose of this systematic review and meta-analysis is to determine if older individuals with HIV are less likely to be non-adherent to antiretroviral therapy than younger individuals with HIV.

Design

A systematic search in PubMed, Embase, and PsycINFO was conducted to identify peer-reviewed articles evaluating adherence to ART in older adults. Two independent reviewers screened abstracts, applied inclusion criteria, and appraised study quality. The bibliographies of qualifying studies were searched. Data were abstracted from studies by two independent authors. Meta-analyses were conducted, and adherence levels were reported as the relative risk of non-adherence in older individuals compared to younger individuals.

Results

The systematic search yielded 1,848 abstracts. Twelve studies met full inclusion criteria. The overall meta-analysis found that older age reduced risk for non-adherence by 27 % (relative risk (RR) 0.72, 95 % confidence interval (CI) 0.64–0.82). Studies assessing both short-term and long-term adherence demonstrated a significant reduction in non-adherence among older patients (RR 0.75, 95 % CI 0.64–0.87 and RR 0.65, 95 % CI 0.50–0.85, respectively).

Conclusions

Older adults with HIV have a reduced risk for non-adherence to ART than their younger counterparts. Future studies should seek to elucidate contributing factors of adherence among older individuals with HIV.
Appendix
Available only for authorised users
Literature
1.
go back to reference Brooks JT, Buchacz K, Gebo KA, Mermin J. HIV infection and older Americans: the public health perspective. Am J Public Health. 2012;2012(102):1516–26.CrossRef Brooks JT, Buchacz K, Gebo KA, Mermin J. HIV infection and older Americans: the public health perspective. Am J Public Health. 2012;2012(102):1516–26.CrossRef
5.
go back to reference Collaboration TATC. Life expectancy of individuals on combination antiretroviral therapy in high-income countries: a collaborative analysis of 14 cohort studies. Lancet. 2008;372:293–9.CrossRef Collaboration TATC. Life expectancy of individuals on combination antiretroviral therapy in high-income countries: a collaborative analysis of 14 cohort studies. Lancet. 2008;372:293–9.CrossRef
6.
go back to reference Abrass CK, Appelbaum JS, Boyd CM, Braithwaite RS, Broudy VC, Covinsky K, et al. HIV and aging consensus project; recommended treatment strategies for clinicians managing older patients with HIV. J Am Geriatr Soc. 2012;60:974–9.CrossRef Abrass CK, Appelbaum JS, Boyd CM, Braithwaite RS, Broudy VC, Covinsky K, et al. HIV and aging consensus project; recommended treatment strategies for clinicians managing older patients with HIV. J Am Geriatr Soc. 2012;60:974–9.CrossRef
7.
go back to reference Paterson DL, Swindells S, Mohr J, Brester M, Vergis EN, Squier C, et al. Adherence to protease inhibitor therapy and outcomes in patients with HIV infection. Ann Intern Med. 2000;133:21–30.PubMedCrossRef Paterson DL, Swindells S, Mohr J, Brester M, Vergis EN, Squier C, et al. Adherence to protease inhibitor therapy and outcomes in patients with HIV infection. Ann Intern Med. 2000;133:21–30.PubMedCrossRef
8.
go back to reference Nguyen N, Holodniy M. HIV infection in the elderly. Clin Interv Aging. 2008;3:453–72.PubMed Nguyen N, Holodniy M. HIV infection in the elderly. Clin Interv Aging. 2008;3:453–72.PubMed
9.
go back to reference Wood E, Hogg RS, Yip B, Harrigan PR, O’Shaughnessy MV, Montaner JS. The impact of adherence on CD4 cell count responses among HIV-infected patients. J Acquir Immune Defic Syndr. 2004;35:261–8.PubMedCrossRef Wood E, Hogg RS, Yip B, Harrigan PR, O’Shaughnessy MV, Montaner JS. The impact of adherence on CD4 cell count responses among HIV-infected patients. J Acquir Immune Defic Syndr. 2004;35:261–8.PubMedCrossRef
10.
go back to reference Maggiolo F, Ripamonti D, Arici C, Gregis G, Quinzan G, Camacho GA, et al. Simpler regimens may enhance adherence to antiretroviral in HIV-infected patients. HIV Clin Trials. 2002;3:371–8.PubMedCrossRef Maggiolo F, Ripamonti D, Arici C, Gregis G, Quinzan G, Camacho GA, et al. Simpler regimens may enhance adherence to antiretroviral in HIV-infected patients. HIV Clin Trials. 2002;3:371–8.PubMedCrossRef
11.
go back to reference Dunham PJ, Karkula JM. Effects of a pharmacy-care program on adherence and outcomes. Am J Pharm Benefits. 2012;4:e8–14. Dunham PJ, Karkula JM. Effects of a pharmacy-care program on adherence and outcomes. Am J Pharm Benefits. 2012;4:e8–14.
12.
go back to reference Viswanathan H, Anderson R, Thomas Iii J. Evaluation of an antiretroviral medication attitude scale and relationships between medication attitudes and medication nonadherence. AIDS Patient Care STDS. 2005;19:306–16.PubMedCrossRef Viswanathan H, Anderson R, Thomas Iii J. Evaluation of an antiretroviral medication attitude scale and relationships between medication attitudes and medication nonadherence. AIDS Patient Care STDS. 2005;19:306–16.PubMedCrossRef
13.
go back to reference Ruppar TM, Conn VS, Russell CL. Medication adherence interventions for older adults: literature review. Res Theory Nurs Pract. 2008;22:114–47.PubMedCrossRef Ruppar TM, Conn VS, Russell CL. Medication adherence interventions for older adults: literature review. Res Theory Nurs Pract. 2008;22:114–47.PubMedCrossRef
14.
go back to reference Johnson MO, Catz SL, Remien RH, Rotheram-Borus MJ, Morin SF, Charlebois E, et al. Theory-guided, empirically supported avenues for intervention on HIV medication nonadherence: findings from the healthy living project. AIDS Patient Care STDS. 2003;17:645–56.PubMedCrossRef Johnson MO, Catz SL, Remien RH, Rotheram-Borus MJ, Morin SF, Charlebois E, et al. Theory-guided, empirically supported avenues for intervention on HIV medication nonadherence: findings from the healthy living project. AIDS Patient Care STDS. 2003;17:645–56.PubMedCrossRef
15.
go back to reference Holodniy M, Hornberger J, Rapoport D, Robertus K, MaCurdy TE, Lopez J, et al. Relationship between antiretroviral prescribing patterns and treatment guidelines in treatment-naive HIV-1-infected US veterans (1992–2004). J Acquir Immune Defic Syndr. 2007;44:20–9.PubMedCrossRef Holodniy M, Hornberger J, Rapoport D, Robertus K, MaCurdy TE, Lopez J, et al. Relationship between antiretroviral prescribing patterns and treatment guidelines in treatment-naive HIV-1-infected US veterans (1992–2004). J Acquir Immune Defic Syndr. 2007;44:20–9.PubMedCrossRef
16.
go back to reference Barclay TR, Hinkin CH, Castellon SA, Mason KI, Reinhard MJ, Marion SD, et al. Age-associated predictors of medication adherence in HIV-positive adults: health beliefs, self-efficacy, and neurocognitive status. Health Psychol. 2007;26:40–9.PubMedCrossRef Barclay TR, Hinkin CH, Castellon SA, Mason KI, Reinhard MJ, Marion SD, et al. Age-associated predictors of medication adherence in HIV-positive adults: health beliefs, self-efficacy, and neurocognitive status. Health Psychol. 2007;26:40–9.PubMedCrossRef
17.
go back to reference Cuzin L, Delpierre C, Gerard Sp, Massip P, Marchou B. Immunologic and clinical responses to highly active antiretroviral therapy in patients with HIV infection aged 150 years. Clin Infect Dis. 2007;45:654–7.PubMedCrossRef Cuzin L, Delpierre C, Gerard Sp, Massip P, Marchou B. Immunologic and clinical responses to highly active antiretroviral therapy in patients with HIV infection aged 150 years. Clin Infect Dis. 2007;45:654–7.PubMedCrossRef
18.
go back to reference Sherr L, Harding R, Lampe F, Johnson M, Anderson J, Zetler S, et al. Clinical and behavioural aspects of aging with HIV infection. Psychol Health Med. 2009;14:273–9.PubMedCrossRef Sherr L, Harding R, Lampe F, Johnson M, Anderson J, Zetler S, et al. Clinical and behavioural aspects of aging with HIV infection. Psychol Health Med. 2009;14:273–9.PubMedCrossRef
19.
go back to reference Stroup DF, Berlin JA, Morton SC, et al. Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis Of Observational Studies in Epidemiology (MOOSE) group. JAMA. 2000;283:2008–12.PubMedCrossRef Stroup DF, Berlin JA, Morton SC, et al. Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis Of Observational Studies in Epidemiology (MOOSE) group. JAMA. 2000;283:2008–12.PubMedCrossRef
20.
go back to reference Elema R, Mills C, Yun O, Lokuge K, Ssonko C, Nyirongo N, et al. Outcomes of a remote, decentralized health center-based HIV/AIDS antiretroviral program in Zambia, 2003 to 2007. J Int Assoc Physicians AIDS Care (Chic). 2009;8:60–7.CrossRef Elema R, Mills C, Yun O, Lokuge K, Ssonko C, Nyirongo N, et al. Outcomes of a remote, decentralized health center-based HIV/AIDS antiretroviral program in Zambia, 2003 to 2007. J Int Assoc Physicians AIDS Care (Chic). 2009;8:60–7.CrossRef
21.
go back to reference Mathes T, Pieper D, Antoine SL, Eikermann M. Adherence-enhancing interventions for highly active antiretroviral therapy in HIV-infected patients - a systematic review. HIV Med. 2013 (Epub ahead of print). Mathes T, Pieper D, Antoine SL, Eikermann M. Adherence-enhancing interventions for highly active antiretroviral therapy in HIV-infected patients - a systematic review. HIV Med. 2013 (Epub ahead of print).
22.
go back to reference Mills EJ, Nachega JB, Buchan I, Orbinski J, et al. Adherence to antiretroviral therapy in sub-Saharan Africa and North America: a meta-analysis. JAMA. 2006;296:679–90.PubMedCrossRef Mills EJ, Nachega JB, Buchan I, Orbinski J, et al. Adherence to antiretroviral therapy in sub-Saharan Africa and North America: a meta-analysis. JAMA. 2006;296:679–90.PubMedCrossRef
24.
go back to reference Higgins J. Heterogeneity in meta-analyses should be expected and appropriately quantified. Int J Epidemiol. 2008;37:1158–60.PubMedCrossRef Higgins J. Heterogeneity in meta-analyses should be expected and appropriately quantified. Int J Epidemiol. 2008;37:1158–60.PubMedCrossRef
25.
go back to reference Sterne JAC, Bradburn MJ, Egger M. Meta-analysis in Stata™. In: Egger M, Smith GD, Altman DG, editors. Systematic reviews in health care: meta-analysis in context. 2nd ed. London: BMJ Publishing Group; 2008. Sterne JAC, Bradburn MJ, Egger M. Meta-analysis in Stata™. In: Egger M, Smith GD, Altman DG, editors. Systematic reviews in health care: meta-analysis in context. 2nd ed. London: BMJ Publishing Group; 2008.
26.
go back to reference Lyimo R, van den Boogarden J, Msoka E, et al. Measuring adherence to antiretroviral therapy in northern Tanzania: feasibility and acceptability of the Medication Event Monitoring System. BMC Public Health. 2011;11:1–20.CrossRef Lyimo R, van den Boogarden J, Msoka E, et al. Measuring adherence to antiretroviral therapy in northern Tanzania: feasibility and acceptability of the Medication Event Monitoring System. BMC Public Health. 2011;11:1–20.CrossRef
27.
go back to reference Kyser M, Buchacz K, Bush TJ, et al. Factors associated with non-adherence to antiretroviral therapy in the SUN study. AIDS Care. 2011;23:601–11.PubMedCrossRef Kyser M, Buchacz K, Bush TJ, et al. Factors associated with non-adherence to antiretroviral therapy in the SUN study. AIDS Care. 2011;23:601–11.PubMedCrossRef
28.
go back to reference Hinkin CH, Hardy DJ, Mason KI, et al. Medication adherence in HIV-infected adults: effect of patient age, cognitive status, and substance abuse. AIDS. 2004;18:S19–25.PubMedCrossRef Hinkin CH, Hardy DJ, Mason KI, et al. Medication adherence in HIV-infected adults: effect of patient age, cognitive status, and substance abuse. AIDS. 2004;18:S19–25.PubMedCrossRef
29.
go back to reference Silverberg MJ, Leyden W, Horberg MA, et al. Older age and the response to and tolerability of antiretroviral therapy. Arch Intern Med. 2007;167:684–91.PubMedCrossRef Silverberg MJ, Leyden W, Horberg MA, et al. Older age and the response to and tolerability of antiretroviral therapy. Arch Intern Med. 2007;167:684–91.PubMedCrossRef
30.
go back to reference Sherr L, Lampe FC, Clucas C, et al. Self-reported non-adherence to ART and virological outcome in a multiclinic UK study. AIDS Care. 2010;22:939–45.PubMedCrossRef Sherr L, Lampe FC, Clucas C, et al. Self-reported non-adherence to ART and virological outcome in a multiclinic UK study. AIDS Care. 2010;22:939–45.PubMedCrossRef
31.
go back to reference Simone MJ, Appelbaum J. HIV in older adults. Geriatrics. 2008;63:6–12.PubMed Simone MJ, Appelbaum J. HIV in older adults. Geriatrics. 2008;63:6–12.PubMed
32.
go back to reference Kleeberger CA, Phair JP, Strathdee SA, et al. Determinants of heterogeneous adherence to HIV-antiretroviral therapies in the Multicenter AIDS Cohort Study. J Acquir Immune Defic Syndr. 2001;26:82–92.PubMed Kleeberger CA, Phair JP, Strathdee SA, et al. Determinants of heterogeneous adherence to HIV-antiretroviral therapies in the Multicenter AIDS Cohort Study. J Acquir Immune Defic Syndr. 2001;26:82–92.PubMed
33.
go back to reference Dowshen N, D’Angelo L. Health care transition for youth living with HIV/AIDS. Pediatrics. 2011;128(4):762–71.PubMedCrossRef Dowshen N, D’Angelo L. Health care transition for youth living with HIV/AIDS. Pediatrics. 2011;128(4):762–71.PubMedCrossRef
34.
go back to reference Greene M, Justice AC, Valcour V, et al. Management of human immunodeficiency virus infection in advanced age. JAMA. 2013;309:1397–405.PubMedCrossRef Greene M, Justice AC, Valcour V, et al. Management of human immunodeficiency virus infection in advanced age. JAMA. 2013;309:1397–405.PubMedCrossRef
36.
go back to reference Working Group on HIV and Aging. HIV and aging: state of knowledge and areas of critical need for research. A report to the NIH Office of AIDS Research by the HIV and Aging Working Group. J Acquir Immune Defic Syndr. 2012;60:S1–18.CrossRef Working Group on HIV and Aging. HIV and aging: state of knowledge and areas of critical need for research. A report to the NIH Office of AIDS Research by the HIV and Aging Working Group. J Acquir Immune Defic Syndr. 2012;60:S1–18.CrossRef
37.
go back to reference Johnson CJ, Heckman TG, Hansen NB, et al. Adherence to antiretroviral medication in older adults living with HIV/AIDS: a comparison of alternative models. AIDS Care Psychol Soc Med Aspects AIDS/HIV. 2009;21(5):541–51.CrossRef Johnson CJ, Heckman TG, Hansen NB, et al. Adherence to antiretroviral medication in older adults living with HIV/AIDS: a comparison of alternative models. AIDS Care Psychol Soc Med Aspects AIDS/HIV. 2009;21(5):541–51.CrossRef
38.
go back to reference Tumbarello M, Rabagliati R, de Gaetano Donati K, Bertagnolio S, et al. Older age does not influence CD4 cell recovery in HIV-1 infected patients receiving highly active antiretroviral therapy. BMC Infect Dis. 2004;4:1–32.CrossRef Tumbarello M, Rabagliati R, de Gaetano Donati K, Bertagnolio S, et al. Older age does not influence CD4 cell recovery in HIV-1 infected patients receiving highly active antiretroviral therapy. BMC Infect Dis. 2004;4:1–32.CrossRef
39.
go back to reference Shah B, Walshe L, Saple DG, et al. Adherence to antiretroviral therapy and virologic suppression among HIV-infected persons receiving care in private clinics in Mumbai, India. Clin Infect Dis. 2007;44:1235–44.PubMedCrossRef Shah B, Walshe L, Saple DG, et al. Adherence to antiretroviral therapy and virologic suppression among HIV-infected persons receiving care in private clinics in Mumbai, India. Clin Infect Dis. 2007;44:1235–44.PubMedCrossRef
40.
go back to reference Gellad WF, Grenard JL, Marcum ZA. A systematic review of barriers to medication adherence in the elderly: looking beyond cost and regimen complexity. Am J Geriatr Pharmacother. 2011;9:11–23.PubMedCrossRef Gellad WF, Grenard JL, Marcum ZA. A systematic review of barriers to medication adherence in the elderly: looking beyond cost and regimen complexity. Am J Geriatr Pharmacother. 2011;9:11–23.PubMedCrossRef
41.
go back to reference Ladefoged K, Andersson M, Koch A, et al. Living conditions, quality of life, adherence and treatment outcome in Greenlandic HIV patients. Int J Circumpolar Health. 2012;71:1–8. Ladefoged K, Andersson M, Koch A, et al. Living conditions, quality of life, adherence and treatment outcome in Greenlandic HIV patients. Int J Circumpolar Health. 2012;71:1–8.
42.
go back to reference Raboud J, Li M, Walmsley S, et al. Once daily dosing improves adherence to antiretroviral therapy. AIDS Behav. 2011;15:1397–409.PubMedCrossRef Raboud J, Li M, Walmsley S, et al. Once daily dosing improves adherence to antiretroviral therapy. AIDS Behav. 2011;15:1397–409.PubMedCrossRef
43.
go back to reference Kunutsor S, Evans M, Thoulass J, et al. Ascertaining baseline levels of antiretroviral therapy adherence in Uganda: a multimethod approach. J Acquir Immune Defic Syndr. 2010;55:221–4.PubMedCrossRef Kunutsor S, Evans M, Thoulass J, et al. Ascertaining baseline levels of antiretroviral therapy adherence in Uganda: a multimethod approach. J Acquir Immune Defic Syndr. 2010;55:221–4.PubMedCrossRef
44.
go back to reference Pinheiro CA, de-Carvalho-Leite JC, Drachler ML, et al. Factors associated with adherence to antiretroviral therapy in HIV/AIDS patients: a cross-sectional study in Southern Brazil. Braz J Med Biol Res. 2002;35:1173–81.PubMedCrossRef Pinheiro CA, de-Carvalho-Leite JC, Drachler ML, et al. Factors associated with adherence to antiretroviral therapy in HIV/AIDS patients: a cross-sectional study in Southern Brazil. Braz J Med Biol Res. 2002;35:1173–81.PubMedCrossRef
45.
go back to reference Wellons MF, Sanders L, Edwards LJ, et al. HIV infection: treatment outcomes in older and younger adults. J Am Geriatr Soc. 2002;50:603–7.PubMedCrossRef Wellons MF, Sanders L, Edwards LJ, et al. HIV infection: treatment outcomes in older and younger adults. J Am Geriatr Soc. 2002;50:603–7.PubMedCrossRef
46.
go back to reference Watt MH, Maman S, Golin CE, et al. Factors associated with self-reported adherence to antiretroviral therapy in a Tanzanian setting. AIDS Care. 2010;22:381–9.PubMedCrossRef Watt MH, Maman S, Golin CE, et al. Factors associated with self-reported adherence to antiretroviral therapy in a Tanzanian setting. AIDS Care. 2010;22:381–9.PubMedCrossRef
47.
go back to reference Buscher A, Hartman C, Kallen MA, Giordano TP. Validity of self-report measures in assessing antiretroviral adherence of newly diagnosed, HAART-naïve HIV patients. HIV Clin Trials. 2011;12:244–54.PubMedCrossRef Buscher A, Hartman C, Kallen MA, Giordano TP. Validity of self-report measures in assessing antiretroviral adherence of newly diagnosed, HAART-naïve HIV patients. HIV Clin Trials. 2011;12:244–54.PubMedCrossRef
48.
go back to reference Fletcher M, Brundage R, Chesney M, et al. Four measures of antiretroviral medication adherence and virologic response in AIDS Clinical Trials Group Study 359. J Acquir Immune Defic Syndr. 2005;40:301–6.PubMedCrossRef Fletcher M, Brundage R, Chesney M, et al. Four measures of antiretroviral medication adherence and virologic response in AIDS Clinical Trials Group Study 359. J Acquir Immune Defic Syndr. 2005;40:301–6.PubMedCrossRef
49.
go back to reference Manfredi R, Chiodo F. A case–control study of virological and immunological effects of highly active antiretroviral therapy in HIV-infected patients with advanced age. AIDS. 2000;14:1475–7.PubMedCrossRef Manfredi R, Chiodo F. A case–control study of virological and immunological effects of highly active antiretroviral therapy in HIV-infected patients with advanced age. AIDS. 2000;14:1475–7.PubMedCrossRef
50.
go back to reference Hinkin CH, Barclay TR, Castellon SA, et al. Drug use and medication adherence among HIV-1 infected individuals. AIDS Behav. 2007;11:185–94.PubMedCrossRef Hinkin CH, Barclay TR, Castellon SA, et al. Drug use and medication adherence among HIV-1 infected individuals. AIDS Behav. 2007;11:185–94.PubMedCrossRef
Metadata
Title
Aging, Antiretrovirals, and Adherence: A Meta Analysis of Adherence among Older HIV-Infected Individuals
Authors
Luwam Ghidei
Mark J. Simone
Marci J. Salow
Kristin M. Zimmerman
Allison M. Paquin
Lara M. Skarf
Tia R. M. Kostas
James L. Rudolph
Publication date
01-10-2013
Publisher
Springer International Publishing
Published in
Drugs & Aging / Issue 10/2013
Print ISSN: 1170-229X
Electronic ISSN: 1179-1969
DOI
https://doi.org/10.1007/s40266-013-0107-7

Other articles of this Issue 10/2013

Drugs & Aging 10/2013 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.